244 related articles for article (PubMed ID: 31951011)
1. High activation and skewed T cell differentiation are associated with low IL-17A levels in a hu-PBL-NSG-SGM3 mouse model of HIV infection.
Perdomo-Celis F; Medina-Moreno S; Davis H; Bryant J; Taborda NA; Rugeles MT; Kottilil S; Zapata JC
Clin Exp Immunol; 2020 May; 200(2):185-198. PubMed ID: 31951011
[TBL] [Abstract][Full Text] [Related]
2. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
Kim KC; Choi BS; Kim KC; Park KH; Lee HJ; Cho YK; Kim SI; Kim SS; Oh YK; Kim YB
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):194-202. PubMed ID: 26564392
[TBL] [Abstract][Full Text] [Related]
3. An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rγnull mice allows HIV replication and development of anti-HIV immune responses.
Singh M; Singh P; Gaudray G; Musumeci L; Thielen C; Vaira D; Vandergeeten C; Delacroix L; Van Gulck E; Vanham G; de Leval L; Rahmouni S; Moutschen M
PLoS One; 2012; 7(6):e38491. PubMed ID: 22675567
[TBL] [Abstract][Full Text] [Related]
4. Improved B cell development in humanized NOD
Jangalwe S; Shultz LD; Mathew A; Brehm MA
Immun Inflamm Dis; 2016 Dec; 4(4):427-440. PubMed ID: 27980777
[TBL] [Abstract][Full Text] [Related]
5. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
[TBL] [Abstract][Full Text] [Related]
6. Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain.
Coughlan AM; Harmon C; Whelan S; O'Brien EC; O'Reilly VP; Crotty P; Kelly P; Ryan M; Hickey FB; O'Farrelly C; Little MA
Stem Cells Dev; 2016 Apr; 25(7):530-41. PubMed ID: 26879149
[TBL] [Abstract][Full Text] [Related]
7. T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.
Rizza P; Santini SM; Logozzi MA; Lapenta C; Sestili P; Gherardi G; Lande R; Spada M; Parlato S; Belardelli F; Fais S
J Virol; 1996 Nov; 70(11):7958-64. PubMed ID: 8892919
[TBL] [Abstract][Full Text] [Related]
8. Alpha interferon and HIV infection cause activation of human T cells in NSG-BLT mice.
Long BR; Stoddart CA
J Virol; 2012 Mar; 86(6):3327-36. PubMed ID: 22238321
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model.
Honeycutt JB; Wahl A; Archin N; Choudhary S; Margolis D; Garcia JV
Retrovirology; 2013 Oct; 10():121. PubMed ID: 24156277
[TBL] [Abstract][Full Text] [Related]
10. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.
Koyanagi Y; Tanaka Y; Kira J; Ito M; Hioki K; Misawa N; Kawano Y; Yamasaki K; Tanaka R; Suzuki Y; Ueyama Y; Terada E; Tanaka T; Miyasaka M; Kobayashi T; Kumazawa Y; Yamamoto N
J Virol; 1997 Mar; 71(3):2417-24. PubMed ID: 9032379
[TBL] [Abstract][Full Text] [Related]
11. Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models.
Pyo KH; Kim JH; Lee JM; Kim SE; Cho JS; Lim SM; Cho BC
Lung Cancer; 2019 Jan; 127():112-121. PubMed ID: 30642538
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
Fais S; Lapenta C; Santini SM; Spada M; Parlato S; Logozzi M; Rizza P; Belardelli F
J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739
[TBL] [Abstract][Full Text] [Related]
13. Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies.
Xia X; Li H; Satheesan S; Zhou J; Rossi JJ
J Vis Exp; 2019 Jan; (143):. PubMed ID: 30663638
[TBL] [Abstract][Full Text] [Related]
14. Minocycline attenuates HIV-1 infection and suppresses chronic immune activation in humanized NOD/LtsZ-scidIL-2Rγ(null) mice.
Singh M; Singh P; Vaira D; Amand M; Rahmouni S; Moutschen M
Immunology; 2014 Aug; 142(4):562-72. PubMed ID: 24409837
[TBL] [Abstract][Full Text] [Related]
15. Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.
Zhang L; Meissner E; Chen J; Su L
Sci China Life Sci; 2010 Feb; 53(2):195-203. PubMed ID: 20596827
[TBL] [Abstract][Full Text] [Related]
16. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
17. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice.
Billerbeck E; Barry WT; Mu K; Dorner M; Rice CM; Ploss A
Blood; 2011 Mar; 117(11):3076-86. PubMed ID: 21252091
[TBL] [Abstract][Full Text] [Related]
18. A novel humanized mouse model for HIV and tuberculosis co-infection studies.
Bohórquez JA; Adduri S; Ansari D; John S; Florence J; Adejare O; Singh G; Konduru NV; Jagannath C; Yi G
Front Immunol; 2024; 15():1395018. PubMed ID: 38799434
[TBL] [Abstract][Full Text] [Related]
19. Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression.
Brehm MA; Kenney LL; Wiles MV; Low BE; Tisch RM; Burzenski L; Mueller C; Greiner DL; Shultz LD
FASEB J; 2019 Mar; 33(3):3137-3151. PubMed ID: 30383447
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
